456 related articles for article (PubMed ID: 25958032)
1. Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds.
Sundahl N; Bridelance J; Libert C; De Bosscher K; Beck IM
Pharmacol Ther; 2015 Aug; 152():28-41. PubMed ID: 25958032
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
Stahn C; Löwenberg M; Hommes DW; Buttgereit F
Mol Cell Endocrinol; 2007 Sep; 275(1-2):71-8. PubMed ID: 17630118
[TBL] [Abstract][Full Text] [Related]
3. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
Vandevyver S; Dejager L; Tuckermann J; Libert C
Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
[TBL] [Abstract][Full Text] [Related]
4. Natural and synthetic compounds as dissociated agonists of glucocorticoid receptor.
Zhang T; Liang Y; Zhang J
Pharmacol Res; 2020 Jun; 156():104802. PubMed ID: 32278042
[TBL] [Abstract][Full Text] [Related]
5. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
De Bosscher K; Beck IM; Haegeman G
Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids and the non-steroidal selective glucocorticoid receptor modulator, compound A, differentially affect colon cancer-derived myofibroblasts.
Drebert Z; Bracke M; Beck IM
J Steroid Biochem Mol Biol; 2015 May; 149():92-105. PubMed ID: 25666906
[TBL] [Abstract][Full Text] [Related]
7. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
Schäcke H; Berger M; Rehwinkel H; Asadullah K
Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
[TBL] [Abstract][Full Text] [Related]
8. Targeting inflammation using selective glucocorticoid receptor modulators.
De Bosscher K; Haegeman G; Elewaut D
Curr Opin Pharmacol; 2010 Aug; 10(4):497-504. PubMed ID: 20493772
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
[TBL] [Abstract][Full Text] [Related]
10. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
Löwenberg M; Stahn C; Hommes DW; Buttgereit F
Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
[TBL] [Abstract][Full Text] [Related]
11. Novel glucocorticoid receptor agonists in the treatment of asthma.
Cazzola M; Coppola A; Rogliani P; Matera MG
Expert Opin Investig Drugs; 2015; 24(11):1473-82. PubMed ID: 26293110
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory actions of Caesalpinin M2 in experimental colitis as a selective glucocoricoid receptor modulator.
Xiang G; Fan M; Ma Y; Wang M; Gao J; Chen J; Li X; Xue W; Wang Y; Gao H; Shen Y; Xu Q
Biochem Pharmacol; 2018 Apr; 150():150-159. PubMed ID: 29427627
[TBL] [Abstract][Full Text] [Related]
13. [New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].
Huisman AM; Jacobs JW; Buttgereit F; Bijlsma JW
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):476-80. PubMed ID: 16553045
[TBL] [Abstract][Full Text] [Related]
14. SEGRAs: a novel class of anti-inflammatory compounds.
Schäcke H; Hennekes H; Schottelius A; Jaroch S; Lehmann M; Schmees N; Rehwinkel H; Asadullah K
Ernst Schering Res Found Workshop; 2002; (40):357-71. PubMed ID: 12355726
[TBL] [Abstract][Full Text] [Related]
15. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
McMaster A; Ray DW
Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619
[TBL] [Abstract][Full Text] [Related]
16. Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases.
Kato M; Hagiwara Y; Oda T; Imamura-Takai M; Aono H; Nakamura M
J Ocul Pharmacol Ther; 2011 Aug; 27(4):353-60. PubMed ID: 21574866
[TBL] [Abstract][Full Text] [Related]
17. Activation of the Glucocorticoid Receptor in Acute Inflammation: the SEDIGRAM Concept.
De Bosscher K; Beck IM; Ratman D; Berghe WV; Libert C
Trends Pharmacol Sci; 2016 Jan; 37(1):4-16. PubMed ID: 26603477
[TBL] [Abstract][Full Text] [Related]
18. Discovery of New non-steroidal selective glucocorticoid receptor agonists.
Potamitis C; Siakouli D; Papavasileiou KD; Boulaka A; Ganou V; Roussaki M; Calogeropoulou T; Zoumpoulakis P; Alexis MN; Zervou M; Mitsiou DJ
J Steroid Biochem Mol Biol; 2019 Feb; 186():142-153. PubMed ID: 30321666
[TBL] [Abstract][Full Text] [Related]
19. It takes two to tango: dimerisation of glucocorticoid receptor and its anti-inflammatory functions.
Nixon M; Andrew R; Chapman KE
Steroids; 2013 Jan; 78(1):59-68. PubMed ID: 23127816
[TBL] [Abstract][Full Text] [Related]
20. [Current insights into the development of new glucocorticoid receptor ligands].
Buttgereit F; Song IH; Straub RH; Burmester GR
Z Rheumatol; 2005 Apr; 64(3):170-6. PubMed ID: 15868334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
